Quimi Daphne 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Quimi Daphne
Corporate Controller
Transactions
- Sale
Common Stock
2023-01-18$13.00/sh−6,923$89,999→ 398,532 total - Sale
Common Stock
2023-01-17$12.49/sh−5,000$62,444→ 405,455 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.34 to $12.70. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.